00000nam 2200000za 4500 9.845494 CaOODSP 20221107153000 cr ||||||||||| 171013s2017 oncd ob f000 0 eng d CaOODSP eng n-cn--- YN5-127/2017E-PDF Busby, Carleigh. Federal cost of a national pharmacare program [electronic resource]. Ottawa : Office of the Parliamentary Budget Officer, 2017. 88 p. : col. charts Issued also in French under title: Coût d’un programme national d’assurance-médicaments de régie fédérale. Cover title. "28 September 2017." Written by: Carleigh Busby. Cf. p. [3] of cover. Includes bibliographical references. “In September 2016, the House of Commons Standing Committee on Health asked the Parliamentary Budget Officer (PBO) to provide a cost estimate of implementing a national Pharmacare program. The Committee provided the program’s framework, including the inclusive list of drugs to be covered by Pharmacare based on Quebec’s formulary, eligibility requirements, co-payment levels, and eligibility requirements for co-payment exemptions. This paper estimates the cost to the federal government of implementing this particular framework for Pharmacare. It incorporates PBO’s assumptions of the potential savings resulting from a stronger position for drug price negotiations, consumption or behavioural responses of providing coverage, and potential changes in the drug market composition. In addition, this paper provides five-year projections of these federal costs. However, the costs associated with a single administrator of drug benefit claims when compared to multiple administrators both public and private are not considered"--Executive summary, p. 1. gccst Drug insurance gccst Costs Canada. Office of the Parliamentary Budget Officer. Coût d’un programme national d’assurance-médicaments de régie fédérale (CaOODSP)9.845496 PDF 993 KB https://publications.gc.ca/collections/collection_2017/dpb-pbo/YN5-127-2017-eng.pdf